 BEIJING, Nov. 13, 2020 PRNewswire -- China Biologic Products Holdings, Inc. NASDAQ: CBPO China Biologic or the Company, a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2020 financial... 